---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-182567"
form_type: "8-K"
ticker: "ACH"
cik: "0000075252"
company_name: "ACCENDRA HEALTH INC/VA/"
filed_at: "2024-07-23T23:59:59+00:00"
generated_at: "2026-05-31T18:19:13.848049+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Owens & Minor reports preliminary Q2 GAAP net loss $0.42-0.46/share, adj. EPS $0.32-$0.36; reaffirms FY guidance

## Summary
- Revenue $2,651-$2,671M; GAAP net loss per share $(0.42)-$(0.46); adjusted EPS $0.32-$0.36.
- One-time income tax charge of $17M ($0.22/share) from transfer pricing dispute; expected cash payment $30-$35M in H2 2024.
- Full-year 2024 outlook reaffirmed: revenue $10.5-$10.9B, adj. EBITDA $550-$590M, adj. EPS $1.40-$1.70.
- Adjusted EBITDA $123-$127M; operating cash flow $111-$116M; net debt reduction $68-$71M.
- Full Q2 results to be released on August 2, 2024, before NYSE open.

## SEC filing metadata
- accession: 0001193125-24-182567
- form_type: 8-K
- ticker: ACH
- cik: 0000075252
- company_name: ACCENDRA HEALTH INC/VA/
- filed_at: 2024-07-23T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/75252/000119312524182567/0001193125-24-182567-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/75252/000119312524182567/d857019d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-182567
- JSON: https://secwatch.observer/filing/0001193125-24-182567.json
- Plain text: https://secwatch.observer/filing/0001193125-24-182567.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.